Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aalberts stock logo
AALBF
Aalberts
$32.93
-10.7%
$35.94
$28.65
$39.92
N/AN/A1,097 shs123 shs
BVII
(BVII)
$0.00
$0.03
$0.10
N/AN/A3,442 shsN/A
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
$11.81
-0.5%
$11.92
$10.13
$15.26
N/AN/A15,777 shs26,510 shs
TDCH
30DC
$0.00
$0.00
$0.07
N/AN/A30,535 shsN/A
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aalberts stock logo
AALBF
Aalberts
0.00%-10.69%-10.69%+9.06%-18.40%
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
-0.80%-3.43%+0.74%+0.47%+1.72%
TDCH
30DC
0.00%0.00%0.00%0.00%-99.63%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aalberts stock logo
AALBF
Aalberts
0.1806 of 5 stars
0.00.01.70.00.60.80.6
BVII
(BVII)
N/AN/AN/AN/AN/AN/AN/AN/A
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
N/AN/AN/AN/AN/AN/AN/AN/A
TDCH
30DC
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aalberts stock logo
AALBF
Aalberts
0.00
N/AN/AN/A
BVII
(BVII)
0.00
N/AN/AN/A
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
0.00
N/AN/AN/A
TDCH
30DC
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aalberts stock logo
AALBF
Aalberts
N/AN/AN/AN/AN/AN/A
BVII
(BVII)
N/AN/AN/AN/AN/AN/A
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
N/AN/AN/AN/AN/AN/A
TDCH
30DC
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aalberts stock logo
AALBF
Aalberts
N/A$1.2725.98N/AN/AN/AN/AN/A
BVII
(BVII)
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
N/A$4.992.37N/AN/AN/AN/A8/21/2025 (Estimated)
TDCH
30DC
N/A-$0.01N/AN/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aalberts stock logo
AALBF
Aalberts
$0.351.06%N/A27.50%N/A
BVII
(BVII)
N/AN/AN/AN/AN/A
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
N/AN/AN/AN/AN/A
TDCH
30DC
N/AN/AN/AN/AN/A

Latest SHTDY, BVII, TDCH, and AALBF Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/14/2025
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
$0.35422.91%6/17/20256/18/20258/27/2025
(Data available from 1/1/2013 forward)

Institutional Ownership

CompanyInstitutional Ownership
Aalberts stock logo
AALBF
Aalberts
46.99%
BVII
(BVII)
N/A
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
N/A
TDCH
30DC
0.08%

Insider Ownership

CompanyInsider Ownership
Aalberts stock logo
AALBF
Aalberts
N/A
BVII
(BVII)
N/A
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
N/A
TDCH
30DC
18.33%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aalberts stock logo
AALBF
Aalberts
14,055N/AN/ANot Optionable
BVII
(BVII)
147,000N/AN/ANot Optionable
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
115,959N/AN/ANot Optionable
TDCH
30DC
10N/AN/ANot Optionable

Recent News About These Companies

Used Toyota 4Runner for sale in Lexington, IL
30DC Inc
Garmin discount codes for June 2023
Tech Deals & Buying Guides
How Professors’ Tech Paranoia Hinders Higher Ed
Everyday Tech
Tech News
Tech BLOGS
TEXAS TECH RED RAIDERS NEWS
TECH POLICY

New MarketBeat Followers Over Time

Media Sentiment Over Time

Aalberts stock logo

Aalberts OTCMKTS:AALBF

$32.93 -3.94 (-10.69%)
As of 07/30/2025 09:47 AM Eastern

Aalberts N.V. offers mission-critical technologies for aerospace, automotive, building, and maritime sectors. It operates through Building Technology and Industrial Technology sectors. The Building Technology segment develops, manufactures, and monitors hydronic flow control systems for heating and cooling to enhance the energy efficiency; and develops, designs, and manufactures integrated piping systems to distribute and regulate water or gas flows in heating, cooling, water, gas, and sprinkler systems in eco-friendly buildings and industrial niches. The Industrial Technology segment co-develops, engineers, and manufactures advanced mechatronics and technologies to regulate, measure, and control fluids under severe and critical conditions for active OEMs in semicon efficiency, sustainable transportation, and industrial niches; and offers a range of surface technologies utilizing a network of service locations local knowledge to customers active in sustainable transportation and industrial niches. It operates in Western Europe, the United States, Russia, Eastern Europe, the Asia-Pacific, the Middle East, and Africa. The company was formerly known as Aalberts Industries N.V. and changed its name to Aalberts N.V. in April 2019. Aalberts N.V. was founded in 1975 and is headquartered in Utrecht, the Netherlands.

(BVII) OTCMKTS:BVII

Broadview Institute, Inc. is a career-focused post-secondary education services company. The Company operates primarily through its subsidiary, C Square Educational Enterprises, Inc. (Broadview University). Broadview University has campuses located in the Utah cities of Layton, Orem, Salt Lake City and West Jordan, as well as Boise, Idaho. Broadview University is accredited by the Accrediting Council for Independent Colleges and Schools (ACICS) to award diplomas, undergraduate degrees, and master's degrees in various fields of study. The Company's admissions department interviews potential applicants, provides information regarding its academic programs, and assists with the overall application process. The Company helps its students to complete their program of study through admissions screening, financial planning and student services. The Company's classes are offered in the day and evening, and many courses are available through online delivery. It also provides assistance.

Sinopharm Group stock logo

Sinopharm Group OTCMKTS:SHTDY

$11.81 -0.06 (-0.51%)
As of 08/1/2025 03:58 PM Eastern

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.

30DC OTCMKTS:TDCH

30DC, Inc. provides digital media solutions. The company primarily provides MagCast Publishing Platform, a cloud-based digital publishing software which enables customers to create mobile magazine apps, as well as facilitates the monetization of digital content through advanced marketing functions. It also offers related training courses and support services. The company was founded in 2005 and is based in New York, New York.